PMFA
IRWD icon

Plante Moran Financial Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Plante Moran Financial Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-94
Closed -$2K – 802
2018
Q2 		$2K Sell
94
-52
-36% -$770 ﹤0.01% 729
2018
Q1 		$2K Buy
146
+52
+55% +$648 ﹤0.01% 843
2017
Q4 		$1K Hold
94
– – ﹤0.01% 833
2017
Q3 		$1K Buy
+94
New +$1.29K ﹤0.01% 772

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Plante Moran Financial Advisors's IRWD Position: Q3 2018 in Review

Plante Moran Financial Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2018, closing a stake of 94 shares — an estimated $2K sold.

Plante Moran Financial Advisors first reported a position in IRWD in Q3 2017 and held it in 4 quarters. The position peaked at $2K in Q2 2018. 151 funds tracked by Wall St. Rank hold IRWD as of Q3 2018.

  • Plante Moran Financial Advisors reported no remaining Ironwood Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 94 Ironwood Pharmaceuticals shares in Q3 2018, an estimated $2K.
  • Plante Moran Financial Advisors first reported a position in Ironwood Pharmaceuticals in Q3 2017 and held it in 4 quarters.
  • Plante Moran Financial Advisors's Ironwood Pharmaceuticals position peaked at $2K in Q2 2018.
  • 151 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2018.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.